GLOW keeps the focus on collagen, blood supply, and repair-cell movement
2018;378:e34
Dual-component blend: GHRH-R agonist (CJC-1295, Modified GRF 1-29) + GHSR-1a agonist pentapeptide (Ipamorelin) The pathways CJC / IPA Blend acts on and what each one does
ADVANCED DOSE : At week 9, your dose can increase to 1 mg once a week to maintain results and no more than 1mg
SURMOUNT-1 Tirzepatide The pivotal tirzepatide trial, published in the New England Journal of Medicine in 2022, randomized 2,539 adults with obesity to tirzepatide 5 mg, 10 mg, 15 mg or placebo for 72 weeks
often patchy) Recent illness, surgery, COVID-19, or major stress Low calorie or low protein intake (even without medication) Certain medications that can trigger shedding (retinoids, some anticonvulsants, chemotherapy) Traction from hairstyles or scalp conditions (inflammation, scaling) Because of this, patchy hair loss, scarring, scalp pain, or shedding lasting longer than 69 months should be evaluated by a clinician rather than assumed to be telogen effluvium